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Single-cell RNA sequencing reveals
dynamic changes in A-to-I RNA editome
during early human embryogenesis
Si Qiu1,2†, Wenhui Li2†, Heng Xiong2, Dongbing Liu2, Yali Bai2,3, Kui Wu2,4, Xiuqing Zhang2, Huanming Yang2,5,
Kun Ma2*, Yong Hou2,4* and Bo Li2,6*
Abstract
Background: A-to-I RNA-editing mediated by ADAR (adenosine deaminase acting on RNA) enzymes that converts
adenosine to inosine in RNA sequence can generate mutations and alter gene regulation in metazoans. Previous
studies have shown that A-to-I RNA-editing plays vital roles in mouse embryogenesis. However, the RNA-editing
activities in early human embryonic development have not been investigated.
Results: Here, we characterized genome-wide A-to-I RNA-editing activities during human early embryogenesis by
profiling 68 single cells from 29 human embryos spanning from oocyte to morula stages. We demonstrate dynamic
changes in genome-wide RNA-editing during early human embryogenesis in a stage-specific fashion. In parallel
with ADAR expression level changes, the genome-wide A-to-I RNA-editing levels in cells remained relatively stable
until 4-cell stage, but dramatically decreased at 8-cell stage, continually decreased at morula stage. We detected 37
non-synonymously RNA-edited genes, of which 5 were frequently found in cells of multiple embryonic stages.
Moreover, we found that A-to-I editings in miRNA-targeted regions of a substantial number of genes preferably
occurred in one or two sequential stages.
Conclusions: Our single-cell analysis reveals dynamic changes in genome-wide RNA-editing during early human
embryogenesis in a stage-specific fashion, and provides important insights into early human embryogenesis.
Keywords: RNA-editing, Single cell transcriptome, Embryogenesis
Background
A-to-I RNA-editing mediated by ADAR (adenosine
deaminase acting on RNA) enzymes is the major RNA-
editing that post-transcriptionally modifies nucleotide
sequences on RNA molecules in metazoans [1]. RNA-
editing can alter protein sequences, influence RNA
stability and miRNA regulations in multiple biological
processes including development and carcinogenesis
[2]. The mammalian ADAR proteins include ADAR,
ADARB1, and ADARB2 [3].
Recent studies have demonstrated that most mice with
a null allele of ADAR died before E14 due to defects in
the hematopoietic system [4], and most mice with
editing deficient ADAR mutation knock-in died at E13.5
as a result of unedited transcripts activating interferon
and dsRNA sensing pathway [5]. Shtrichman et al. [6]
found that editing levels of various target genes are sub-
stantially greater in most adult tissues than corresponding
fetal ones and that ADAR protein is substantially regulated
in undifferentiated pluripotent hESCs. These findings sug-
gest that RNA-editing plays important roles in embryo-
genesis. Although early human embryonic transcriptome
profiles have been studied [7–9], no research on RNA-
editing activities before blastocyst stage during human
embryogenesis has been conducted. To investigate RNA-
editing activities during early embryogenesis in humans,
we profiled the RNA editome from 68 single cells from 29
human embryos ranging from oocyte to morula stages
using published human embryonic single cell transcrip-
tome data [8, 9].
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Results
Characteristics of RNA editome during early human
embryogenesis
By analyzing 68 single cells from 29 human embryos
spanning from oocyte to morula stages in early embryo-
genesis (Additional file 1: Figure S1) using our RNA
identification pipeline, we identified 14,049 candidate
RNA mismatches, including 9,795 in Alu and 4,254 in
non-Alu regions. Of the 9,795 mismatches in Alu regions
we identified, A-to-G was the most prevalent mismatch
type (account for 88.04 %), followed by T-to-C mis-
matches (account for 11.61 %), of which the majority were
thought to be incorrect annotation of A-to-I editing be-
cause the RNA-seq libraries were not strand-specific [10].
The A-to-G and T-to-C mismatches together account for
99.65 % of the sites identified in Alu region (Fig. 1a). A
typical ADAR-mediated editing is characterized by under-
representation of G base in position −1 next to the edited
site and over-representation of G base in position +1 next
to the edited site [11]. Indeed, this characteristic was seen
at our identified A-to-G sites and at the complementary
strand of T-to-C sites (Fig. 1b). Of the 4,254 candidate
RNA editing sites identified in non-Alu regions 2,247 were
A-to-G mismatches (52.82 %) and 488 were T-to-C
mismatches (11.47 %). The proportion of A-to-G/T-to-C
mismatches in non-Alu regions is smaller than those in
Alu regions (Fig. 1a). Similar findings have been reported
by Fumagalli et al. [12] when they studied RNA-DNA sin-
gle nucleotide differences (RDDs) in breast cancer. Con-
sidering that the proportion of validated RDDs was 90 %
in Alu region and below 40 % outside Alu region in their
study, and that the majority of editing events are in Alu
elements in human [13], we only retain non-Alu A-to-G
mismatches recorded in RADAR database [14] and Alu
A-to-G mismatches as candidate A-to-I RNA-editing sites
in our further analyses.
Totally, we identified 8,813 candidate A-to-I RNA-
editing sites (Additional file 2: Table S1), of which 97.84 %
located in Alu regions and 3,253 sites were present in the
RADAR database. We annotated A-to-I RNA-editing sites
and found that the majority were located in 3’-UTR
regions (47.12 %), followed by intronic (33.77 %), non-
coding RNA (ncRNA, 17.12 %), coding (0.98 %), and 5’-
UTR regions (1.01 %), respectively (Fig. 1c). We noticed
that the proportion of intronic A-to-I editing sites identi-
fied in our study is much smaller than that (94.03 %) in
RADAR database, which may due to the low-coverage of
the single cell RNA-seq data we analyzed. We will discuss
this issue later on.
On average, we detected 819 ± 609, 702 ± 64, 953 ± 377,
1,057 ± 557, and 743 ± 330 A-to-I RNA-editing sites in
each cell at oocyte, pronucleus, zygote, 2-cell, and 4-cell
stages, respectively, whereas in cells at 8-cell and morula
stages the A-to-I RNA-editing sites sharply dropped to
only 190 ± 97 and 86 ± 35 per cell, respectively (Fig. 1d).
To investigate the changes in RNA-editing patterns during
human early embryogenesis, we clustered single cells
based on editing frequencies (defined as the variant-
supporting reads divided by all reads mapped to a specific
RNA-editing site), and found that cells at 8-cell and
morula stages were clustered together and separated
from cells at earlier stages (Fig. 1e). The heatmap shows
that ~15 % of A-to-I RNA-editing sites present in cells
crossing from oocyte to 4-cell stages, but not in cells at
8-cell and morula stages, despite of expression of tran-
scripts at moderate levels (Fig. 1e).
A-to-I RNA-editing levels are sharply decreased in cells at
8-cell and morula stages
To profile genome-wide A-to-I RNA-editing changing pat-
terns in the embryonic development, we defined A-to-I
RNA-editing level as edited bases per million mapped bases
in each cell. Under this definition, A-to-I RNA-editing
levels are not affected by the number of mapped bases
(Pearson’s correlation test, P = 2.11E-01, r = −0.15; Fig. 2a).
We observed that on average the RNA-editing levels
remained relatively stable until 4-cell stage, but dramatic-
ally decreased (68 %) from 4-cell to 8-cell stages (Wilcoxon
rank sum test, P = 7.92E-6), and continually decreased
(41 %) at morula stage (Wilcoxon rank sum test, P =
1.48E-02; Fig. 2b and Additional file file 1: Figure S2). We
then investigated the gene expression of ADAR, ADARB1,
and ADARB2 in cells at different stages, and found that
ADARB1 and ADARB2 expression remained at low level
(~1 Reads Per Kilobase per Million mapped reads, RPKM)
across all embryonic stages investigated (Fig. 2c). The sub-
stantially lower expression of ADARB1 than ADAR is also
seen in many tissues in adult humans (Table S2) [15].
Amazingly, the changes in ADAR expression levels were
almost in parallel with the changes in editing levels in cells
at all stages investigated (Fig. 2b and Additional file 1:
Figure S3). Correlation tests indicated that RNA-editing
levels were strongly correlated with ADAR expression
levels (Pearson’s correlation test, P = 5.99E-13, r = 0.74;
Fig. 2d). Interestingly, we noticed the largest decreases
in ADAR expression level and in A-to-I RNA-editing
level occurred in the cells at 8-cell stage. It is worth noting
that although the ADARB1 expression levels remained
low in cells of all stages investigated, we detected a moder-
ate correlation between the ADARB1 expression levels
and the A-to-I RNA-editing levels (Pearson’s correlation
test, P = 3.38E-4, r = 0.42; Fig. 2e).
Non-synonymous A-to-I RNA-editing events frequently
occurred in cells before 8-cell stage
We detected 324 A-to-I RNA editing events at 54 non-
synonymous sites on 37 genes, of which 292 non-
synonymous A-to-I RNA-editing events on 36 genes
Qiu et al. BMC Genomics  (2016) 17:766 Page 2 of 11
A0
50
100%
 o
f s
ite
s
Stages
O P Z 2 4 8 M
%
 o
f G
 in
 p
os
iti
on
O P Z 2 4 8 M
0
50
B
CDS UTR5
O P Z 2 4 8 M
0
50
100
%
 o
f s
ite
s
0
1
2
O P Z 2 4 8 M
E
di
tin
g 
si
te
s 
(K
)
C D
2−cell
4−cell
8−cell
Morula
Oocyte
Pronucleus
Zygote
Stages
0 0.95
FrequencyE
Stages
Stages Stages
100
0
50
100
50
100
Alu
non-Alu
0
- 1 upstream C%
+1 downstream C%
- 1 upstream G%
+1 downstream G%
UTR3
Intron
ncRNA
Fig. 1 (See legend on next page.)
Qiu et al. BMC Genomics  (2016) 17:766 Page 3 of 11
Fig. 2 ADARs govern changes in A-to-I RNA-editing levels during early human embryogenesis. a No correlation between editing level and mapped
bases. b Changes in RNA-editing levels during early human embryogenesis. * P < 0.05; ** P < 0.01; *** P < 0.001 (Wilcoxon rank sum test). c Changes
in gene expression of ADAR, ADARB1, and ADARB2 during early human embryogenesis. Each colored dot (red, black, and blue) represents the gene
expression levels of ADAR, ADARB1, and ADARB2 in a cell. d and e Correlation between editing levels and the expression levels of ADAR and ADARB1.
Each dot represents one cell
(See figure on previous page.)
Fig. 1 Characteristics of candidate RNA-editings in cells during early human embryogenesis. a Percentages of mismatch types in each cell. Each
column represents one cell. b Neighbor preferences for A-to-G (top) and T-to-C (bottom) sites in each cell. A-to-G sites and the complementary
strand of T-to-C sites display the motif signature of ADAR mediated A-to-I editing. Each pair of dots and triangles represents the G/C base % at
position −1 (blue) and +1 (red) in one cell. c Percentages of A-to-I RNA-editing sites in functional genome elements at different stages. ncRNA,
noncoding RNA. Each column represents one cell. d Changes in candidate A-to-I RNA-editing sites at different stages. Each bar represents one
cell. O: oocyte; P: pronucleus; Z: zygote; 2: 2-cell; 4: 4-cell; 8: 8-cell; M: morula. e RNA-editing frequency at each editing site (column) in each cell
(row). Blank regions, uniquely mapped reads < 4, not qualified for RNA-editing determination
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occurred in cells before 8-cell stage (Fig. 3a). Among
the 54 nonsynonymous sites, 27 sites were deposited in
RADAR (Additional file 2: Table S3). In addition, we
observed that 7 genes were each non-synonymously
edited at a specific embryonic stage.
We found that AZIN1, DCAF16, SLC3A1, TTF1, and
NSMCE2 were non-synonymously edited in more than
25 % of cells, almost exclusively confined to stages before
8-cell. Previous study showed that the non-synonymous
RNA-editing sites in AZIN1 (A1099G, ENST00000347770)
and DCAF16 (A486G, ENST00000382247) are clinically
relevant in cancers [16]. We observed that the A1099G
editing events on AZIN1 occurred in 3 of 6 oocytes, 3 of 3
pronuclei, 5 of 5 zygotes, 6 of 9 2-cell cells, 14 of 15 4-cell
cells, 4 of 20 8-cell cells and none in morulae cells, respect-
ively, and the A486G editing events on DCAF16 occurred
in 3 of 6 oocytes, 3 of 3 pronuclei, 4 of 5 zygotes, 7 of 9 2-
cell cells, 6 of 15 4-cell cells, none in 20 8-cell cells and 2
of 10 morulae cells, respectively. In 32 cells, we detected
41 non-synonymous A-to-I RNA-editing events at three
sites (A1630G, A1646G, and A1691G, ENST00000409387)
in the extracellular topological domain of SLC3A1, which
encodes a renal amino acid transporter [17]. We found
non-synonymous A-to-I RNA-editing events at three sites
(A2651G, A2677G, and A2678G, ENST00000334270)
altering the TTF1 C-terminal amino acid sequence, which
was suggested to mediate the termination of ribosomal
gene transcription [18]. In addition, we found non-
synonymous A-to-I RNA-editing events frequently
altered the amino acid sequence of NSMCE2 (A262G
and A268G, ENST00000519712), which is required for
DNA repair [19].
Editing frequencies at the exonic RNA editing sites of four
genes are negatively associated with their expression
We conducted Spearman’s correlation analysis between
gene expression and editing frequency on 163 genes
which were edited in the exon regions and found that
A-to-I RNA-editing frequencies were negatively asso-
ciated with the expression of four frequently edited
genes (adjusted P < 0.1, Benjamini-Hochberg method).
For instance, the frequency of non-synonymous editing
Fig. 3 Recoding RNA-editing events in cells during early embryonic stages. a Heatmap of non-synonymous RNA-editing events in cells during
early embryonic stages. Each row represents a cell, and each column represents a non-synonymous A-to-I editing site. Frequently edited genes
are highlighted with dashed lines. Blank regions, uniquely mapped reads < 4, not qualified for RNA-editing determination. b Changes in non-
synonymous editing frequency are negatively associated with the gene expression of AZIN1. Left, changes in AZIN1’s editing frequency; middle,
changes in AZIN1’s expression; right, editing frequency is negatively associated with the AZIN1 expression level, each open circle represents one
single cell. * P < 0.05; ** P < 0.01; *** P < 0.001
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A1099G on AZIN1 dramatically dropped from 4-cell
to 8-cell stages (Wilcox rank sum test, P = 2.67E-6;
Fig. 3b) while the AZIN1 expression substantially
increased (edgeR, P = 3.24E-17; Fig. 3b). We found that
AZIN1 expression was highly negatively associated
with editing frequency of A1099G (Spearman’s correl-
ation test, r = −0.60, adjusted P = 2.02E-05, Fig. 3b).
This pattern was also seen in protein coding genes
DCAF16 (Spearman’s correlation test, r = −0.43, adjusted
P = 1.99E-02, Additional file 1: Figure S4A), and in long
intergenic noncoding RNAs RPL23AP53 (Spearman’s cor-
relation test, r = −0.58, adjusted P = 2.63E-03, Additional
file 1: Figure S4B) and SNHG16 (Small Nucleolar
RNA Host Gene 16) which was suggested to be asso-
ciated with cell proliferation [20] (Spearman’s correl-
ation test, r = −0.57, adjusted P = 4.66E-05, Additional
file 1: Figure S4C).
A-to-I RNA-editing events in miRNA-targeted mRNA re-
gions of many genes preferably occur at specific stages
It has been suggested that RNA-editing in miRNA-
targeted regions could alter miRNA-mediated post-
transcriptional gene silencing [21] and gene expression
[22]. We identified 609 A-to-I RNA-editing sites in
miRNA-targeted regions on 298 genes (Additional file 2:
Table S4), and noticed that the editing sites are relatively
stable in cells from oocyte to 4-cell stages (57 ± 51, 25 ±
5, 62 ± 39, 68 ± 43, 61 ± 29 in oocyte, pronucleus, zygote,
2-cell, and 4-cell stages, respectively). However, the edit-
ing sites in cells at 8-cell and morula stages sharply
dropped to 13 ± 8 and 4 ± 2, respectively (Additional file
1: Figure S5). We noticed that the editing events in
miRNA-targeted regions on 114 genes, enriched in cell
cycle (GSEA, adjusted P = 5.94E-08, Additional file 2:
Table S5), occurred preferably in cells crossing oocyte to
4-cell stages (Fisher’s exact test, P < 0.05).
In addition to the differences in quantities of editing
sites at different stages, A-to-I RNA-editing in miRNA-
targeted regions on a substantial number of genes ap-
pears to be stage related. By calculating the percentage
of cells with editing events in miRNA-targeted regions
on each gene at each stage, we found that a group of 19
genes were more frequently edited in oocytes than in
cells of other stages (Fisher’s exact test, P < 0.05),
whereas a different group of 13 genes were more fre-
quently edited in zygotes (Fisher’s exact test, P < 0.05),
and another group of 36 genes were more frequently
edited in cells at 2-cell stage (Fisher’s exact test, P < 0.05).
Interestingly, the number of genes that were more fre-
quently edited in miRNA-targeted regions increased to 42
in cells at 4-cell stage but suddenly decreased to 4 in cells
at 8-cell stage (Fig. 4a). In addition, we observed a small
number of genes that were more frequently edited in
miRNA-targeted regions in cells crossing two sequential
stages than other stages. For instance, one group of 5
genes were more frequently edited at zygote and 2-cell
stages, while another 9 genes were more frequently edited
at 2-cell and 4-cell stages (Fig. 4a). We noticed that 16
genes involved in generic transcription pathway and 18
genes involved in cell cycle, were edited in miRNA-tar-
geted regions at most stages (Fig. 4b and c). Interest-
ingly, NUP43 and MCM4 involved in cell cycle were
frequently edited in miRNA-targeted regions in cells
across zygote to 4-cell stages (Fig. 4b).
Discussion
In this study, we detected genome-wide A-to-I RNA-
editing in cells ranging from oocyte to morula stages,
and defined editing-level to reflect RNA-editing activities
in a cell. We showed that A-to-I RNA-editing levels
dramatically decreased at 8-cell stage. By looking at the
impacts of A-to-I RNA-editing on protein recoding, we
found that seven genes such as AZIN1 were frequently
non-synonymously edited in cells of multiple embry-
onic stages.
We noticed that the proportion of intronic A-to-I editing
sites identified in our study (33.70 %) is much smaller than
that (94.03 %) in RADAR. Because introns are retained
only in premature mRNA of genes, the sequencing depths
in intron regions are usually lower than those in exon re-
gion of expressed genes in RNA-seq. Because the single
cell RNA-seq data we analyzed are low-coverage, thus, the
depths of many intronic regions are less than 4, which do
not meet our requirement for determination of RNA
editing events. This leads to a substantial reduction in
A-to-I RNA editing sites being identified in intron
regions, consequently largely reducing the percentage
of intronic A-to-I RNA editing sites among the total A-
to-I RNA editing sites identified.
Human embryogenesis is a complex and genetically
well-programmed developmental process that is con-
trolled by cascades of genes. Our results indicated that
A-to-I RNA-editing acted in a stage-specific fashion dur-
ing human early embryogenesis. We noticed that
genome-wide A-to-I editing level suddenly and dramat-
ically dropped in cells at 8-cell stage, suggesting that this
sudden drop of A-to-I RNA-editing level may have an
important biological significance during human early
embryogenesis. Although the biological function of this
sudden drop of editing level is yet to be discovered, we
consider this event particularly interesting. Previous
studies suggested that the 8-cell stage is a turning point
because many important biological events occur at this
stage. For example, a recent study on human early em-
bryogenesis showed that there was a dramatic change in
gene expression in cells at 8-cell stage as compared to
the previous stages. At 8-cell stage, the expression of
3037 genes, enriched with genes involved in regulation
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of transcription and regulation of RNA metabolic process,
substantially up-regulated while 1941 genes, enriched with
genes involved in regulation of transcription and cell cycle,
substantially down-regulated [9]. The X chromosome
inactivation (XCI) is an important mechanism that com-
pensates for the difference in gene dosage between XX
females and XY males in mammals. Interestingly, the XCI
in humans appears to start from the 8-cell stage [23].
Moreover, embryonic left-right separation is an important
event during embryogenesis of bilaterians. In a recent
study, by analyzing multiple lines of molecular and cell
biology evidence, Ma concluded that embryos of bila-
terians are divided into left and right lateral halves at or
shortly after 8-cell stage [24].
AZIN1 plays a role in cell growth and proliferation by
maintaining polyamine homeostasis within cells [25]. A
non-synonymous editing (A1099G) on AZIN1 was found
to be conserved in human and mouse [11]. Previous
study showed that the A1099G edited AZIN1 resulted in
substantially enhancing cell proliferation in cultured
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specific stage and other stages (right). Vertical bars highlight the genes that are more frequently edited in miRNA-targeted regions at one (black)
or two sequential stages (blue) than other stages. Arabic numeral denotes the number of genes in each group. b and c Heatmaps of the frequencies
of cells edited on genes involved in cell cycle and in generic transcription pathway, respectively. Each column represents an embryonic stage, and each
row represents a gene
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liver cell lines [25]. In addition, previous studies showed
that the editing frequencies at this site were significantly
higher in tumors than in matched nontumorous tissues
in hepatocellular carcinoma and esophageal squamous
cell carcinoma [25, 26]. Besides, AZIN1 expression was
significantly increased in esophageal tumors compared
with their matched nontumor specimens [26]. We ob-
served that A1099G edited AZIN1 are present in 31 out
of 38 cells crossing from oocyte to 4-cell stages, and 4
out of 20 cells at 8-cell stages. Intriguingly, the editing
frequency at this site dramatically dropped from 4-cell
to 8-cell stage while the AZIN1 expression substantially
increased. We found that AZIN1 expression was highly
and negatively correlated with the A1099G editing fre-
quencies. As either increase in A1099G editing or high
expression of AZIN1 may promote cell proliferation, we
speculate that the frequent A1099G editing in earlier
stages may be a compensation of the low level of AZIN1
expression. When embryos produce more AZIN1, a de-
crease in edited AZIN1 could keep the stability of overall
AZIN1 activity. We believe that the underlying biological
significance of the frequent A1099G editing on AZIN1
and the function of the A1099G edited AZIN1 during
human early embryogenesis requires further investiga-
tion. We also believe that the negative association
between the AZIN1 expression and the A1099G editing
frequencies during early human embryogenesis is par-
ticularly interesting, deserving more comprehensive
investigation.
Conclusions
Taken together, our study indicates that human embryos
undergo dynamic changes in genome-wide A-to-I RNA-
editing during human early embryogenesis. Our findings
underscore the importance of A-to-I RNA-editing dur-
ing early human embryogenesis. It is worth noting that
our findings are based on the observation of 68 cells
from 29 embryos across 7 embryonic stages. Therefore
we believe it is necessary to conduct more comprehen-
sive studies to verify our findings and to understand the
biological significance of the dynamic changes in A-to-I
editing during human early embryogenesis.
Methods
Reads mapping and pre-processing
We downloaded single cell RNA-seq data of human em-
bryos spanning from oocyte to morula stages from two
previous studies [8, 9] from NCBI database. In both
studies, RNA libraries were sequenced on Illumina plat-
form but not strand-specific. Xue et al., sequenced the
libraries as 90 bp-long pair-end reads, while Yan et al.,
obtained 100 bp-long single-end reads. We noticed that
the sequencing quality near the 3’-ends of some single-
end reads were not satisfactory. Therefore, we trimmed
off 15 bp from the 3’-end of every single-end sequen-
cing read to eliminate sequencing errors. We used
SOAPnuke to filter out reads from both studies that
contained adapters and low quality using default par-
ameter. We downloaded the hg19 (GRCh37) genome
sequences from the UCSC Genome Browser (http://
genome.ucsc.edu). We aligned the filtered reads with
Tophat2 [27] using command:
Tophat2 –read-gap-length 3 –read-edit-dist 3 –no-
novel-juncs –no-novel-indels –transcriptome-index =
transcriptome-index hg19.
The transcriptomes-index is generated using ensemble
gene set. The command is:
Tophat2 -G Homo_sapiens.GRCh37.75.gtf
–transcriptome-index = transcriptome-index hg19.
Then we removed PCR-induced duplications using
Picard (v1.84; http://broadinstitute.github.io/picard/)
and recalibrated base quality using GATK (v2.8-1).
RNA-editing detection
We only selected the data of 68 single cells from 29 em-
bryos each with over 0.5 Gb uniquely mapped bases for
further analyses. We summarized the base calls of pre-
processed aligned RNA-reads to the human reference in
pileup format. To identify candidate RNA-editing sites,
we only used sequencing bases with base-quality ≥ 20.
We determined RNA-editing sites as follows:
1) We perform statistical tests based on binomial
distribution B (n, p) to distinguish true variants
from sequencing errors on every mismatch site,
where p denotes the background mismatch rate
of each transcriptome, and n denotes sequencing
depth on this site. On a given specific site with k
reads supporting variant in all n mapped reads, we
use B (k, n, p) to calculate the probability that the
k mismatches are all due to sequencing errors.
This probability is adjusted using the Benjamini-
Hochberg method. We only retain candidate sites
with adjusted P-value < 0.01. In addition, the candi-
date variant sites should be with mapped reads ≥ 4,
variant-supporting reads ≥3, and mismatch fre-
quencies (variant-supporting-reads/mapped-
reads) ≥ 0.1.
2) We filter out variants with strand bias, referring
to abnormal distribution of sense strand variant
supporting reads and antisense strand variant
supporting reads in sequencing data. This
sequencing bias may introduce false positive. We
estimated strand bias and filtered out variants
with strand bias as follows. (a) We performed a
two-tailed Fisher’s exact test (FET) using the
following two-by-two table:
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(b) We estimated variant strand frequency (sense-
strand variant-supporting reads divided by total
variant-supporting reads), variant strand preference
[absolute (variant strand frequency minus 0.5)],
reference strand frequency (sense-strand reference
minus supporting read number divided by total ref-
erence-supporting read number), and reference strand
preference [absolute (reference strand frequency minus
0.5)]. (c) We filtered out variant sites displaying signifi-
cant strand bias, defined as either FET P-value < 0.005
plus variant strand preference > reference strand pref-
erence, or variant strand frequency > 0.9, or variant
strand frequency < 0.1.
3) Because the mismatches at ends of sequencing reads
are less credible than the ones in the middle of reads,
therefore, we filter out variants with position bias, i.e.
the majority of variant supporting bases are located at
read ends. Read end is defined as 10 bp at 3’-end or
5 bp at 5’-end. Position bias are defined as either FET
P-value < 0.05 plus read end frequency > read middle
frequency, or read end frequency > 0.9.
4) To reduce false positives introduced by misalignment
of sequencing reads to high similarity regions of the
reference sequences, we perform a realignment
filtering. Specifically, we extract variant-supporting
reads on candidate variant sites and realign them
against a combination reference (hg19 genome +
ensemble transcript reference v75) by bwa-0.6.2.
We retain a candidate variant site if at least 90 % of
its variant-supporting reads are realigned to this
site.
5) We remove variant sites that are either in simple
repeat regions (http://hgdownload.cse.ucsc.edu/
goldenpath/hg19/database/), or in homopolymer
regions (runs of ≥ 5 bp). For sites located in non-
Alu regions, we additionally remove the sites
within 5 bp from a splicing site.
6) To filter out common DNA SNPs, we build combined
DNA SNP datasets from dbSNP (V138), 1000
Genome SNP (Phase 3), and human populations
of Dutch [28], Mongolian (unpublished), and Dai
(unpublished). Candidate variants are filtered out if
they are found in the combined DNA SNP datasets.
7) For rare SNPs filtering, we filter out RNA variants
that are only detected in one embryo, because
true editing sites are often present in different
individuals, whereas rare SNPs are most likely
not, as Ramaswami suggested [10].
8) We also filter out candidate RNA variants if their
mismatch frequencies > 0.95.
Finally, we tried to filter out private DNA-induced vari-
ants using the exon DNA sequencing data from the father
of 12 embryos in Xue’s study. We found no additional
paternal exonic DNA variants in the RNA mismatches we
identified (Additional file 1: Table S6), suggesting that the
false positive rate of DNA-induced RNA variants within
the RNA mismatches we identified is considerably low.
Hierarchical clustering
In cluster analysis, we created a matrix C (i, k) to store the
editing frequency (0 for no edit and −1 for depth < 4) on
site i in sample k. We calculated the euclidean distances
among cells based on this matrix using the dist() function
and performed hierarchical clustering using the hclust()
function with default parameters. Both functions could be
found in R package stats. The heatmap was drawn using R
package pheatmap.
Gene expression analyses
We calculate the number of reads aligned to each gene
using the featureCounts function in R package Rsubread
[29]. We performed differential gene expression analyses
using the R package edgeR [30]. The RPKM values and
differential expression P-values of genes used in this
study were reported by edgeR.
RNA-editing sites annotation
We used ANNOVAR [31, 32] to functionally annotate
RNA-editing sites. The gene set used in annotation in-
cluding ensemble gene set v75 and NONCODE v4
[33]. When studying the editing in miRNA-target re-
gions, we focused on regions that were complementary
to miRNA seed within 3’ untranslated regions based
on the predicted miRNA targeted regions downloaded
from http://www.microrna.org/microrna/getDown-
loads.do (August 2010 release, good mirSVR scores).
Gene set enrichment analysis
The gene set enrichment analysis is performed on
website http://software.broadinstitute.org/gsea/msigdb/
annotate.jsp [34, 35]. The gene sets we used to compute
overlaps included Canonical pathways (CP), BioCarta
gene sets (CP:BIOCARTA), KEGG gene sets (CP:KEGG)
and Reactome gene sets (CP:REACTOME).
Additional files
Additional file 1: Figure S1. RNA sequencing data summary. Figure
S2. Changes in RNA-editing levels during early human embryogenesis in
each study. Figure S3. Changes in ADAR expression levels during early
human embryogenesis. Figure S4. Changes in exonic editing frequency
Sense strand variant
supporting reads
Sense strand reference
supporting reads
Antisense strand variant
supporting reads
Antisense strand reference
supporting reads
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are negatively associated with the gene expression of DCAF16, RPL23AP53
and SNHG16. Figure S5. Changes in editing sites in miRNA-targeted mRNA
regions. Table S2. ADAR and ADARB1 expression in different tissues revealed
by Illumina Body Map project. Table S6. exonic DNA filter efficiency of the
17 cells from 12 embryos in Xue’s study. (DOC 775 kb)
Additional file 2: Table S1. Candidate A-to-I RNA-editing sites. Table
S3. Editing levels of A-to-I RNA-editing events that may recode the
proteins. Table S4. Editing levels of A-to-I RNA-editing events in
miRNA-targeted mRNA regions. Table S5. Significant GSEA results of
the genes that are preferably edited in miRNA-targeted regions in
cells crossing oocyte to 4-cell stages. (XLSX 582 kb)
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GSEA: Gene set enrichment analysis; lincRNAs: Long intergenic noncoding
RNAs; ncRNA: Noncoding RNA; RPKM: Reads Per Kilobase per Million mapped
reads; XCI: X chromosome inactivation
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